Matthew C. Stubbs

Transformation from committed progenitor to leukaemia stem cell initiated by MLL–AF9

Andrei V. Krivtsov, David Twomey, Zhaohui Feng et al. · Nature · 2006 · 1.5K citations

Developmental Biology, Cell Division, Medicine +8

HOXA9 is required for survival in human MLL-rearranged acute leukemias

Joerg Faber, Andrei V. Krivtsov, Matthew C. Stubbs et al. · Blood · 2008 · 327 citations · Full text

Cell of origin determines clinically relevant subtypes of MLL-rearranged AML

Andrei V. Krivtsov, María E. Figueroa, Amit Sinha et al. · Leukemia · 2012 · 201 citations · Full text

Hematological Malignancy, Medicine, Immunology +5

MLL-AF9 and FLT3 cooperation in acute myelogenous leukemia: development of a model for rapid therapeutic assessment

Matthew C. Stubbs, Yong‐Mi Kim, Andrei V. Krivtsov et al. · Leukemia · 2007 · 116 citations · Full text

Hematological Malignancy, Medicine, Mixed-phenotype Acute Leukemia +10

The BET inhibitor INCB054329 reduces homologous recombination efficiency and augments PARP inhibitor activity in ovarian cancer

Andrew J. Wilson, Matthew C. Stubbs, Phillip Liu et al. · Gynecologic Oncology · 2018 · 109 citations · Full text

Bet Inhibitor Incb054329, Homologous Recombination Efficiency, Medicine +7